STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
6
13F, latest reported quarter
What the filings say about SJ
Insiders, 180 days
-$33.0K net sold
1 seller · 0% of sales under a 10b5-1 plan
Scienjoy insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Scienjoy Holding Corp insiders sold a net $33.0K of stock across 6 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 8, 2026.
The trade is 9.2% of the 54,500 shares held after it.
No other insider sold within 30 days.
6 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Liu Yongsheng sold about $5.8K of SJ on Jun 9, 2026, the largest insider sale at the company on our record; 6 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 8, 2026.
The trade is 8.4% of the 59,500 shares held after it.
No other insider sold within 30 days.
6 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Liu Yongsheng sold about $5.8K of SJ on Jun 9, 2026, the largest insider sale at the company on our record; 6 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 7.2% of the 69,500 shares held after it.
No other insider sold within 30 days.
6 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Liu Yongsheng sold about $5.3K of SJ on Jun 8, 2026, the largest insider sale at the company on our record; 6 funds added in the latest 13F quarter.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SJ planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $33.0K sold by insiders over 180 days, 6 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2022-07-01 to 2023-06-30
Revenue, TTM SJ
FY Dec 2025
$1.7B
FY Dec 2024
$1.7B
FY Dec 2023
$1.7B
FY Dec 2022
$2.0B
FY Dec 2021
$1.7B
Jun 2023
$363.2M
Mar 2023
$304.3M
Dec 2022
$533.8M
Sep 2022
$449.4M
Jun 2022
$506.5M
Mar 2022
$463.4M
Dec 2021
$498.2M
Sep 2021
$412.9M
At each fiscal year end
Single quarter
Net margin, TTM
+7.5%
net income over revenue, 2022-07-01 to 2023-06-30
Net margin, TTM SJ
FY Dec 2025
+7.5%
FY Dec 2024
+7.5%
FY Dec 2023
+7.5%
FY Dec 2022
+9.9%
FY Dec 2021
+10.2%
Jun 2023
+23.3%
Mar 2023
-1.0%
Dec 2022
+0.7%
Sep 2022
+8.6%
Jun 2022
+13.4%
Mar 2022
+18.0%
Dec 2021
-13.5%
Sep 2021
+18.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM SJ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
Mar 2022
n/a
Dec 2021
n/a
Sep 2021
n/a
At each fiscal year end
Single quarter
Debt to equity
0.01x
long-term debt only, 2022-12-31 (6 months older than the period end); equity 2023-06-30
Debt to equity SJ
FY Dec 2025
0.01x
FY Dec 2024
0.01x
FY Dec 2023
0.01x
FY Dec 2022
0.01x
FY Dec 2021
0.01x
Jun 2023
0.01x
Mar 2023
0.01x
Dec 2022
0.01x
Sep 2022
0.01x
Jun 2022
0.01x
Mar 2022
0.01x
Dec 2021
0.01x
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
15.25x
TTM operating cash flow over long-term debt only, 2022-12-31 (6 months older than the period end)
Cash flow to debt SJ
FY Dec 2025
15.25x
FY Dec 2024
15.25x
FY Dec 2023
15.25x
FY Dec 2022
15.25x
FY Dec 2021
28.60x
Jun 2023
15.25x
Mar 2023
15.25x
Dec 2022
15.25x
Sep 2022
28.60x
Jun 2022
28.60x
Mar 2022
28.60x
Dec 2021
28.60x
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.5%
TTM net income over average of 2022-06-30 and 2023-06-30
Return on equity SJ
FY Dec 2025
+10.5%
FY Dec 2024
+10.5%
FY Dec 2023
+10.5%
FY Dec 2022
+19.6%
FY Dec 2021
+26.8%
Jun 2023
+10.5%
Mar 2023
+9.7%
Dec 2022
+19.6%
Sep 2022
+12.9%
Jun 2022
+18.0%
Mar 2022
+23.1%
Dec 2021
+26.8%
Sep 2021
+26.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+8.3%
TTM net income over average of 2022-06-30 and 2023-06-30
Return on assets SJ
FY Dec 2025
+8.3%
FY Dec 2024
+8.3%
FY Dec 2023
+8.3%
FY Dec 2022
+14.9%
FY Dec 2021
+17.9%
Jun 2023
+8.3%
Mar 2023
+7.7%
Dec 2022
+14.9%
Sep 2022
+10.1%
Jun 2022
+13.0%
Mar 2022
+13.6%
Dec 2021
+17.9%
Sep 2021
+19.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+1.6%
operating income after a 9.3% effective tax rate, over long-term debt only, 2022-12-31 (6 months older than the period end) plus average of 2022-06-30 and 2023-06-30 minus cash
Return on invested capital SJ
FY Dec 2025
+1.6%
FY Dec 2024
+1.6%
FY Dec 2023
+1.6%
FY Dec 2022
+17.3%
FY Dec 2021
+39.2%
Jun 2023
+1.6%
Mar 2023
+6.7%
Dec 2022
+17.3%
Sep 2022
+5.4%
Jun 2022
+28.8%
Mar 2022
+29.9%
Dec 2021
+39.2%
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+1.5%
operating income (EBIT proxy) over average of 2022-06-30 and 2023-06-30 minus current liabilities
Return on capital employed SJ
FY Dec 2025
+1.5%
FY Dec 2024
+1.5%
FY Dec 2023
+1.5%
FY Dec 2022
+14.2%
FY Dec 2021
+23.7%
Jun 2023
+1.5%
Mar 2023
+6.1%
Dec 2022
+14.2%
Sep 2022
+4.2%
Jun 2022
+20.4%
Mar 2022
+16.4%
Dec 2021
+23.7%
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
0.29x
close 2026-10-26 over four quarters of diluted EPS, 2022-07-01 to 2023-06-30
P/E, trailing SJ
FY Dec 2025
0.24x
FY Dec 2024
0.36x
FY Dec 2023
1.22x
FY Dec 2022
0.40x
FY Dec 2021
1.03x
Jun 2023
0.96x
Mar 2023
1.62x
Dec 2022
0.40x
Sep 2022
0.81x
Jun 2022
0.76x
Mar 2022
0.81x
Dec 2021
1.03x
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
-$270.2M
market value at close 2026-10-26 on 2020-12-31 shares, plus long-term debt only, 2022-12-31 (6 months older than the period end), minus cash 2025-12-31
Enterprise value SJ
FY Dec 2025
-$273.9M
FY Dec 2024
-$209.4M
FY Dec 2023
-$96.4M
FY Dec 2022
-$107.0M
FY Dec 2021
-$79.4M
Jun 2023
-$113.7M
Mar 2023
-$54.1M
Dec 2022
-$107.0M
Sep 2022
-$91.0M
Jun 2022
-$79.0M
Mar 2022
-$76.0M
Dec 2021
-$79.4M
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield SJ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
Mar 2022
n/a
Dec 2021
n/a
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -33%, PEG needs growth
PEG, trailing SJ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
Mar 2022
n/a
Dec 2021
n/a
Sep 2021
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SJ ranks highest on risk and compliance (90th percentile) and financial health (87th), and lowest on institutional and government (8th), among Software & IT peers.
Profitability
50
Inputs
Return on equity+10.5% · 64 pct, sector of 286
Return on assets+8.3% · 78 pct, sector of 381
Return on invested capital+1.6% · 3 pct, sector of 78
Return on capital employed+1.5% · 55 pct, sector of 294
Financial health
87
Inputs
Debt to equity0.01x · 79 pct, sector of 288
Cash flow to debt15.25x · 96 pct, sector of 241
Growth
22
Inputs
Revenue growth, YoY-4.9% · 22 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
38
Inputs
Net Form 4 buying (codes P and S), 180d-$33K · 77 pct, sector of 284
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
8
Inputs
Funds adding, latest quarter6 · 8 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
90
Inputs
Short interest, % of float+0.1% · 90 pct, sector of 528
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SJ filings, in plain words
Are Scienjoy insiders buying or selling SJ?
In the 180 days to 2026-10-28, Scienjoy insiders were net sellers, a net $33.0K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Scienjoy insiders were net sellers of SJ, a net $33.0K across purchases and sales reported on Form 4 by 1 seller. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.